Mark A. Dickson

About Me

I am a medical oncologist who specializes in the treatment of sarcomas of soft tissue and bone, Kaposi’s sarcoma, and melanoma. My research is focused on the development of new drugs, including targeted small molecules and antibodies, to treat these diseases.  In particular, I study new drugs that block pathways and proteins critical for cancer growth such as the cell cycle pathway in liposarcoma, the Aurora kinase proteins in soft tissue sarcoma, and the Notch pathway in melanoma.  My research includes work in HIV-associated Kaposi’s sarcoma in concert with the AIDS Malignancy consortium.  My goal is to find newer, more-effective, and less-toxic therapies to improve the lives of people living with cancer.

Read more
  • Clinical Expertise: Sarcomas of Soft Tissue and Bone; Kaposi’s Sarcoma; Melanoma
  • Languages Spoken: English
  • Education: MD, Columbia University College of Physicians & Surgeons
  • Residencies: New York-Presbyterian Hospital/Weill Cornell Medical Center
  • Fellowships: Memorial Sloan Kettering Cancer Center
  • Board Certifications: Internal Medicine; Hematology; Medical Oncology

New Patient Appointments

Making an appointment

Call 646-497-9067


Visit PubMed for a full listing of Mark A. Dickson’s journal articles

Pubmed is an online index of biomedical articles maintained by the U.S. National Library of Medicine and the National Institutes of Health.

Clinical Trials

Research is integral to our mission at Memorial Sloan Kettering, and clinical trials help us discover better forms of patient care and treatment. For you, this could mean access to a new therapy or therapy combination. Click to see a list of the trials I’m currently leading.